Categories: HealthcareNews

Teladoc Health to Announce Second Quarter 2023 Financial Results

PURCHASE, NY, July 10, 2023 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2023 results on Tuesday, July 25, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details
The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 447516. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=51877. A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.

Investors:
Patrick Feeley
914-265-7925
IR@teladochealth.com

Staff

Recent Posts

Shifa Health Marks 21 Years of Transformative Mental Health Care

A Celebration of Innovation, Compassion, and Community EngagementEVERETT, WA / ACCESSWIRE / April 3, 2024…

29 mins ago

Bulletin from the Extraordinary General Meeting of PMD Device Solutions AB held on 3 April 2024

STOCKHOLM, SWEDEN / ACCESSWIRE / April 3, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device…

29 mins ago

AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP 2024

STOCKHOLM, SWEDEN / ACCESSWIRE / April 3, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB…

29 mins ago

Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board

BERLIN, GERMANY / ACCESSWIRE / April 3, 2024 / Berlin Cures, a biotechnology company in…

3 hours ago

Mars Veterinary Health pilots industry-leading anaesthetic gas capture technology to reduce carbon emissions

World's leading provider of veterinary care will be first to introduce innovative in-clinic solution to…

6 hours ago

Gesund.ai Named to the 2024 CB Insights AI 100 List

Gesund.ai recognized for achievements in bringing healthcare AI from the lab to the clinic at…

6 hours ago